Iodine supplement for Graves' hyperthyroidism
Part of Eyes & vision, Hormones & metabolism, Immune system & allergy clinical trials.
This trial tests whether adding iodine supplements to standard antithyroid medication can help people with Graves' hyperthyroidism get their thyroid levels under control more quickly. It may be an option for those who are newly diagnosed or have not yet achieved normal thyroid levels with medication alone.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have Graves' disease with an overactive thyroid and are either newly diagnosed or have been on medication for less than 3 months (or longer but not regularly).
- Your thyroid hormone levels (FT3 or FT4) are higher than normal and your TSH is lower than normal.
- You have a positive TRAb blood test, which means your body is making antibodies that attack your thyroid.
- You do not have a large goiter (thyroid enlargement) that is grade 3 or higher.
- You do not have moderate or severe thyroid eye disease, serious liver or kidney problems, low white blood cell counts, or other major health issues listed in the trial.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether taking Lugol’s iodine solution before thyroid surgery is safe and helpful for people with Graves’ disease or toxic nodular goiter (overactive thyroid). It may be aimed at improving surgical readiness and outcomes by reducing thyroid activity before the operation.
This trial tests an investigational drug called IMVT-1402 for people with Graves' disease whose thyroid is still overactive even while taking standard antithyroid medication. The goal is to see if the drug can better control thyroid hormone levels.
This trial is testing a new drug, BHV-1300, to see if it works and is safe for people with Graves' disease. It might be an option if you have active hyperthyroidism (overactive thyroid) caused by Graves' disease and haven't had certain other treatments.
This trial tests a new drug called IMVT-1402 for adults with Graves' disease whose thyroid is still overactive despite taking antithyroid medication. The goal is to see if the drug can safely help control thyroid hormone levels.
This study tests efgartigimod, a new medicine given by injection under the skin, to see if it can help control Graves' disease (an overactive thyroid condition). The goal is to reduce the need for other thyroid medications or help people stop taking them.
This study compares computer-guided dosing of methimazole (a common thyroid medication) to standard care for people with active Graves' disease. It tests whether digital support helps manage treatment better.
Hear when a new Graves Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.